Submission of intimation of reconstitution of committees.

Novelix Pharmaceuticals has reconstituted three key board committees — Audit Committee, Nomination & Remuneration Committee, and Stakeholders Relationship Committee — effective November 13, 2025. The same three directors, Janardhan Das Kabra (Independent), Mayuri Baidya (Independent), and Jivamohan Divakar Valluri (Non-Independent), now serve across all three committees, with Kabra chairing the Audit and NRC panels and Valluri chairing the Stakeholders Relationship Committee. The change was approved at a board meeting that ran from 5:00 PM to 5:30 PM. The filing is a standard regulatory disclosure under SEBI LODR Regulations 2015, signed by Whole-time Director Venkateshwarlu Pulluru.